"The hypertension market is obviously very large, it has been around a long time, and it is a mature market," explained Bunka before elaborating on the Company's competitors in this sector. "We're all using CBD, but in Lexaria's case, we have clinical data that evidence that with our DehydraTECH process CBD absorbs into the body two to five times more effectively," he explained.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.